NASDAQ : TIL
Instil Bio, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 6.8 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 46.12M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 46.12M |
| Enterprise Value | 63.86M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.78M |
| Shares Outstanding | 6.78M |
| Shares Change (YoY) | +3.61% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.43% |
| Owned by Institutions (%) | 19.12% |
| Float | 3.66M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 21.67 |
| Quick Ratio | 21.09 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.88 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -25.33% |
| Return on Assets (ROA) | -10.77% |
| Return on Invested Capital (ROIC) | -11.23% |
| Return on Capital Employed (ROCE) | -19.00% |
| Weighted Average Cost of Capital (WACC) | 8.88% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.78M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.94 |
| 52-Week Price Change | -61.60% |
| 50-Day Moving Average | 6.96 |
| 200-Day Moving Average | 7.68 |
| Relative Strength Index (RSI) | 56.35 |
| Average Volume (20 Days) | 57,209 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 170,479 |
| Short Previous Month | 159,044 |
| Short % of Shares Out | 2.51% |
| Short % of Float | 4.66% |
| Short Ratio (days to cover) | 7.87 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -36.95M |
| Pretax Income | -30.28M |
| Net Income | -30.28M |
| EBITDA | -36.66M |
| EBIT | -36.95M |
| Earnings Per Share (EPS) | -$4.47 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 69.68M |
| Total Debt | 87.42M |
| Net Cash | -17.74M |
| Net Cash Per Share | -$2.62 |
| Equity (Book Value) | 107.38M |
| Book Value Per Share | 15.83 |
| Working Capital | 68.30M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -23.61M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 284,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -23.61M |
| FCF Per Share | -$3.48 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.61% |
| Shareholder Yield | -3.61% |
| Earnings Yield | -65.71% |
| FCF Yield | -51.20% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 8, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |